Log in

Zur Pathogenese der Antibiotikakolitis: Wirkung von Clostridium difficile Toxin A und B auf die humane Kolonschleimhaut in vitro

Antibiotic-associated colitis: Effect of clostridium difficile toxins A and B on human colonic mucosa in vitro

  • Chirurgische Forschung
  • Published:
Acta chirurgica Austriaca Aims and scope Submit manuscript

Zusammenfassung

Grundlagen: Clostridium difficile ist der Erreger der Antibiotika-assoziierten Enterokolitis. In Tierstudien schädigt Clostridium difficile Toxin A, aber nicht Toxin B die Schleimhaut des Gastrointestinaltraktes. Die Wirkung der Toxine auf die humane Kolonschleimhaut ist unbekannt. Deshalb untersuchten wir in dieser Studie die Wirkung von Clostridium difficile Toxin A (TxA) und Toxin B (TxB) auf die humane Kolonschleimhaut in vitro.

Methodik: Schleimhautpräparationen humanen Kolons wurden in Ussing-Kammern eingebracht und 5 h mit Puffer (Kontrollen) oder Puffer, der an der luminalen Seite 5 bis 20 µg/ml TxA bzw. 0,06 bis 5,0 µg/ml TxB enthielt, inkubiert. Potentialdifferenz (PD), Kurzschlußstrom (Isc) wurden gemessen, der Widerstand (R) errechnet. Das Ausmaß der Mukosaschädigung wurde an mit Hämatoxylin und Eosin (HE) gefärbten Schnitten mittels computergesteuerter Morphometrie gemessen. Das filamentöse (F-) Aktin des Epithelzellskelettes wurde mit Rhodamin beladenem Phalloidin auf Gefrierschnitten gefärbt und im Fluoreszenzmikroskop untersucht.

Ergebnisse: Während die Kontrollen eine normale Morphologie aufwiesen, zeigte die Histologie eine konzentrationsabhängige Schädigung des Oberflächenepithels der Kolonschleimhaut durch TxA und TxB. Das Epithel der Krypten blieb auch bei höchsten Konzentrationen intakt. Entsprechend waren in der Morphometrie nach 5 h luminaler Inkubation mit 5, 10 und 20 µg/ml TxA jeweils 18,6 ± 3%, 33,3 ± 2% bzw. 54 ± 2% der Mukosa geschädigt. Nach Inkubation mit 0,25, 0,5 und 1,0 µg/ ml TxB waren jeweils 9,8 ± 0,6%, 15,6 ± 0,2% bzw. 28,6 ± 0,3% geschädigt (p <0,05). Elektrophysiologie: Zu Versuchsbeginn betrug R in der Kontrollgruppe 174 ± 13 Ohm x cm2, nach 5 h 177 ± 11 Ohm x cm2. 5 h Inkubation mit 5, 10 bzw. 20 µg/ml TxA führte zu einem R-Abfall von jeweils etwa 58, 82 bzw. 136 Ohm x cm2. 5 h Inkubation mit 0,5, 1,0 bzw. 5 µg/ml TxB verursachte einen R-Abfall von jeweils etwa 85, 94 bzw. 169 Ohm x cm2 (p <0.05). Fluoreszenzmikroskopie: Beide Toxine zerstörten das F-Aktin des Zellskelettes der Epithelzellen.

Schlußfolgerungen: Histologie, Morphometrie und Elektrophysiologie zeigen, daß Clostridium difficile TxA und B das Epithel der humanen Kolonschleimhaut in vitro konzentrationsabhängig schädigen und Toxin B, was die Konzentration betrifft, etwa 10mal wirksamer ist als Toxin A.

Summary

Background: In animal models of Clostridium difficile enteritis, toxin A, but not toxin B, appears to mediate intestinal damage. In this study we investigated the morphologic and electrophysiologic effects of purified C. difficile toxins A and B on human colonic mucosa in vitro.

Methods: Human colonic mucosal sheets were mounted in Ussing chambers and incubated with buffer or luminal buffer containing 5 to 20 µg/ml of toxin A and 0.06 to 10 µg/ml of toxin B for 5 h. Potential difference (PD) and short-circuit current (Isc) were measured, resistance (R) was calculated. Histology and Morphometry were performed on hematoxyline and eosine (HE) stained paraffin embedded sections. Flourescent staining of Factin was performed using rhodamin labelled phalloidin.

Results: Histology: Both toxins caused a dose dependent damage of the surface epithelium, while the epithelium lining the crypts remained intact. Morphometry showed that luminal incubation with 5, 10 and 20 µg/ml of TxA caused mucosal damage of 18.6 ± 3%, 33.3 ± 2% and 54 ± 2% respectively. Inkubation with 0.25, 0.5 and 1.0 µg/ml of TxB caused damage of 9.8 ± 0.6%, 15.6 ± 0.2% and 28.6 ± 0.3% respectively (p <0.05). Electrophysiology: At the beginning of the experiments R was 174 ± 13 Ohm x cm2 in the controlgroup, after 5 h R was 177 ± 11 Ohm x cm2. 5-h incubation of tissues with 5, 10 and 20 µg/ml of TxA caused R to drop by 58, 82 and 136 Ohm x cm2, respectively. 5-h incubation with 0.5, 1.0 bzw. 5 µg/ml of TxB caused R to drop by 85, 94, and 169 Ohm x cm2, respectively (p <0.05). Flourescent microscopy of phalloidin stained sections showed that both toxins caused disruption and condensation of cellular filamentous (F-) actin.

Conclusions: Our results demonstrate that the human colon is approximately 10 times more sensitive to the damaging effects of toxin B than toxin A, suggesting that toxin B may be more important that toxin A in the pathogenesis of C. difficile colitis in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Literatur

  1. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL: Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977;136:701–705.

    Article  CAS  PubMed  Google Scholar 

  2. Abrams GD, Allo M, Rifkin GD, Fekety R, Silva J jr: Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut 1980;21:493–499.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bartlett JG, Chang W, Gurwith M, Gorbach SL, Onderdonk AB: Antibiotic associated pseudomembranous colitis due to toxin-producing clostridia. N Eng J Med 1978;298:531–534.

    Article  CAS  Google Scholar 

  4. Bartlett JG, Moon N, Chang W, Taylor N, Onderdonk AB: Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978;75:778–782.

    CAS  PubMed  Google Scholar 

  5. Sullivan NM, Pellet S, Wilkins TD: Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun 1982;35:1032–1040.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Pothoulakis C, Barone LM, Ely R, Faris B, Clark ME, Franzblau C, LaMont JT: Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem 1986;261:1316–1321.

    CAS  PubMed  Google Scholar 

  7. Donta ST, Sullivan N, Wilkins TD: Differential effects of Clostridium difficile toxins on tissue-cultured cells. J Clin Microbiol 1982;15:1157–1158.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Wedel N, Toselli P, Pothoulakis C, Faris B, Oliver P, Franzblau C, LaMont JT: Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts. Exp Cell Res 1983;148:413–422.

    Article  CAS  PubMed  Google Scholar 

  9. Fiorentini C, Thelestam M: Interaction of cytopathogenic toxin from Clostridium difficile toxin A and its effect on cells. Toxicon 1991;29:543–567.

    Article  CAS  PubMed  Google Scholar 

  10. Lyerly DM, Lockwood PE, Richardson SH, Wilkins TD: Biological activities of toxins A and B of Clostridium difficile. Infect Immun 1985;35:1147–1150.

    Google Scholar 

  11. Mitchell TJ, Ketley JM, Haslam SC, Stephen J, Burdon DW, Candy DCA, Daniel R: Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986;27:78–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Triadafilopulos G, Pothoulakis C, O’Brien M, LaMont JT: Differrential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 1987;93:273–279.

    Article  Google Scholar 

  13. Torres J, Jennische E, Lange S, Lönnroth I: Enterotoxins from Clostridium difficile; diarrhogenic potency and morphological effects in the rat intestine. Gut 1990;31:781–785.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ehrich M: Biochemical and pathological effects of Clostridium difficile toxins in mice. Toxicon 1982;20:983–989.

    Article  CAS  PubMed  Google Scholar 

  15. Lyerly DM, Saum KE, McDonald DK, Wilkins TD: Effects of C. difficile toxins given intragastrically to animals. Infect Immun 1985;47:349–352.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kim PH, Iaconis FP, Rolfe RD: Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987;55:2984–2992.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Thelestam M, Florin I: Cytopathogenic action of Clostridium difficile toxins. J Toxicol Toxin Rev 1984;3:139–180.

    Article  CAS  Google Scholar 

  18. Pothoulakis C, Triadafilopoulos G, Clark M, Franzblau C, LaMont JT: Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa. Gastroenterology 1986;91:1147–1153.

    Article  CAS  PubMed  Google Scholar 

  19. Hecht G, Koutsouris A, Pothoulakis C, LaMont JT, Madara JL: Clostridium difficile toxin B disrupts the barrier function of TB4 Monolayers. Gastroenterology 1992;102:416–423.

    Article  CAS  PubMed  Google Scholar 

  20. Hecht G, Pothoulakis C, LaMont JT, Madara JL: Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988;82:1516–1524.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kelly CP, Pothoulakis C, LaMont JT: Current concepts: Clostridium difficile colitis. N Engl J Med 1988;330:257–262.

    Article  Google Scholar 

  22. Pothoulakis C, LaMont JT, Eglow R, Gao N, Rubins JB, Theoharides TC, Dickey BF: Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein. J Clin Invest 1991;88:119–125.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Rolfe RD: Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters. Infect Immun 1991;59:1223–1230.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Eglow R, Pothoulakis C, Itzkowitz S, Israel EJ, O’Keane JC, Dahai D, Gao N, Xu YL, Walker WA, LaMont JT: Diminished Clostridium difficile toxin A sensitivity in newborn rabbit is associated with decreased toxin A receptor. J Clin Invest 1992;90:822–829.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moore R, Pothoulakis C, LaMont JT, Carlson S, Madara JL: C. difficile toxin A increases intestinal permeability and induces Cl secretion. Am J Physiol 1990;259:G165-G172.

    CAS  PubMed  Google Scholar 

  26. Feil W, Lacy E, Wong YM, Burger D, Wenzl E, Starlinger M, Schiessel R: Rapid epithelial restitution of the human and rabbit colonic mucosa. Gastroenterology 1989;97:685–701.

    Article  CAS  PubMed  Google Scholar 

  27. Castagliuolo I, Kelly CP, O’Keane CJ, LaMont JT, Pothoulakis C: The enteric nervous system participates in the inflammatory response to Clostridium difficile toxin A in rat ileum. Gastroenterology 1993;104:A677 (abstr).

    Google Scholar 

  28. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O’Keane JC, Snider RM, Leeman SE: CP-96, 345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci (USA) 1994;91:947–951.

    Article  CAS  Google Scholar 

  29. Pothoulakis C, Karmeli F, Kelly CP, Barone LM, Eliakim R, Joshi MA, O’Keane CJ, Castagliuolo I, J LaMont JT, Rachmilewitz D: Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology 1993;105:701–707.

    Article  CAS  PubMed  Google Scholar 

  30. Flegel WA, Müller F, Daubener W, Fischer HG, Hadding U, Northoff H: Cytokine response by human monocytes to Clostridium difficile toxin A and B. Infect Immun 1991;59:3659–3666.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Kelly CP, Becker S, Linevsky JK, Joshi MA, O’Keane JC, Dickley BF, LaMont JT, Pothoulakis C: Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest 1994;93:1257–1265.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Triadafilopoulos G, Pothoulakis C, Weiss R, Giampaolo C, LaMont JT: Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Role of prostaglandins and leukotrienes. Gastroenterology 1987;92:1174–1180.

    Article  Google Scholar 

  33. Deitch EA, Berg RD: Bacterial translocation from the gut: a mechanism of infection. J Burn Care Rehabil 1987;8:475–482.

    Article  CAS  PubMed  Google Scholar 

  34. Sedman PC, Macfie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, Johnstone D: The prevalence of gut translocation in humans. Gastroenterology 1994;107:643–649.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riegler, M., Sedivy, R., Pothoulakis, C. et al. Zur Pathogenese der Antibiotikakolitis: Wirkung von Clostridium difficile Toxin A und B auf die humane Kolonschleimhaut in vitro. Acta Chir Austriaca 29, 95–101 (1997). https://doi.org/10.1007/BF02619754

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02619754

Schlüsselwörter

Key-words

Navigation